Vanberra Signal

Origent Data Sciences

Curated by Signal

Developer of predictive analytics tools for disease progression, drug discovery and healthcare management

Overview

Origent develops models that predict the progression of diseases for individual patients. Diseases include Alzheimer's Disease, Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease), other neurological diseases, and cancers. Origent's data modeling platform create patient-level predictive models for pharmaceutical companies to measure the efficacy of a drug using small patient populations. These tools allow biotech and pharmaceutical companies to make more informed and earlier strategic decisions about clinical viability of drugs in their development portfolio, while reducing the size of their patient populations for clinical trials.

Key facts

Founded
2004

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of medical healthcare services

    Health TechnologyNashville, United States
  • Develops innovative exoskeleton technologies

    Health TechnologyManchester, United States
  • Provider of hemp-based wellness products to improve health

    Health TechnologyNew York City, United States

About Origent Data Sciences

What does Origent Data Sciences do?

Origent develops models that predict the progression of diseases for individual patients.

Where is Origent Data Sciences headquartered?

Origent Data Sciences is headquartered in Vienna, United States.

When was Origent Data Sciences founded?

Origent Data Sciences was founded in 2004.

Which sector is Origent Data Sciences in?

Origent Data Sciences operates in Health Technology.

Who are Origent Data Sciences's competitors?

Companies similar to Origent Data Sciences include Hatch, Equipois, and MED Rx CBD.